Schrodinger 

$20.71
297
-$0.17-0.81% Thursday 20:00
+$0.03+0.14%Thursday 23:35After hours

Statistics

Day High
21.29
Day Low
20.25
52W High
23.02
52W Low
10.95
Volume
771,476
Avg. Volume
1,198,907
Mkt Cap
1.55B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

11NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.82
-0.52
-0.22
0.08
Expected EPS
-0.69907
Actual EPS
N/A

Financials

-40.36%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
255.87MRevenue
-103.27MNet Income

Analyst Ratings

18.00Average Price Target
The highest estimate is 19.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
100%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SDGR. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Dassault Systemes SA
DASTY
Mkt Cap27.37B
Dassault Systèmes offers software solutions including molecular simulation, competing in the same space as Schrodinger for chemical and materials science research.
RELX
RELX
Mkt Cap63.64B
RELX, through its Elsevier segment, provides scientific, technical, and medical information and analytics which competes with Schrodinger's data-driven drug discovery and materials science solutions.
Thermo Fisher Scientific
TMO
Mkt Cap230.05B
Thermo Fisher Scientific offers a range of analytical instruments and software for research, competing with Schrodinger's computational platforms in life sciences research.
Illumina
ILMN
Mkt Cap32.55B
Illumina provides genomics solutions that, when combined with computational biology, compete with Schrodinger's offerings in drug discovery and development.
Agios Pharmaceuticals
AGIO
Mkt Cap1.99B
Agios Pharmaceuticals focuses on cellular metabolism and rare genetic disorders, competing with Schrodinger in the drug discovery sector, particularly in computational approaches to identifying novel therapeutics.
Pacific Biosciences of California
PACB
Mkt Cap435.16M
Pacific Biosciences offers sequencing systems that, like Schrodinger, contribute to the biotechnology and pharmaceutical industries' research and development efforts.
Guardant Health
GH
Mkt Cap21.67B
Guardant Health operates in the precision oncology field, offering liquid biopsies that compete with Schrodinger's computational approaches in cancer research and drug discovery.
Editas Medicine
EDIT
Mkt Cap485.31M
Editas Medicine works in the genome editing field, which competes with Schrodinger by offering a different approach to drug discovery and development, particularly in designing novel therapeutics.

About

Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.
Show more...
CEO
Ramy Farid
Employees
850
Country
United States
ISIN
US80810D1037
WKN
000A2PY7M

Listings

0 Comments

Share your thoughts

FAQ

What is Schrodinger stock price today?
The current price of SDGR is $20.71 USD — it has decreased by -0.81% in the past 24 hours. Watch Schrodinger stock price performance more closely on the chart.
What is Schrodinger stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Schrodinger stocks are traded under the ticker SDGR.
Is Schrodinger stock price growing?
SDGR stock has risen by +5.13% compared to the previous week, the month change is a +32.33% rise, over the last year Schrodinger has showed a +9.17% increase.
What is Schrodinger market cap?
Today Schrodinger has the market capitalization of 1.55B
When is the next Schrodinger earnings date?
Schrodinger is going to release the next earnings report on November 11, 2026.
What were Schrodinger earnings last quarter?
SDGR earnings for the last quarter are 0.08 USD per share, whereas the estimation was -0.41 USD resulting in a +119.3% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Schrodinger revenue for the last year?
Schrodinger revenue for the last year amounts to 255.87M USD.
What is Schrodinger net income for the last year?
SDGR net income for the last year is -103.27M USD.
How many employees does Schrodinger have?
As of September 04, 2026, the company has 850 employees.
In which sector is Schrodinger located?
Schrodinger operates in the Technology sector.
When did Schrodinger complete a stock split?
Schrodinger has not had any recent stock splits.
Where is Schrodinger headquartered?
Schrodinger is headquartered in NEW YORK, United States.